Telix Pharmaceuticals Limited (TLPPF)

Telix Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	710.35	123.24	116.33	22.04	77.95
Cash & Short-Term Investments	710.35	123.24	116.33	22.04	77.95
Cash Growth	476.41%	5.94%	427.88%	-71.73%	74.77%
Accounts Receivable	139.45	64.78	39.35	0.73	0.16
Other Receivables	10.04	7.1	6.57	20.12	14.03
Receivables	149.48	71.88	45.92	20.85	14.19
Inventory	38.14	17.31	8.48	3.45	0.63
Prepaid Expenses	11.08	12.42	2.51	1.21	0.86
Other Current Assets	9.51	7.66	-	-	-
Total Current Assets	918.56	232.5	173.23	47.54	93.63
Property, Plant & Equipment	54.32	30.49	18.84	6.33	4.82
Long-Term Investments	6.09	12.26	-	-	-
Goodwill	106.65	4.85	5.52	4.1	4.22
Other Intangible Assets	309.49	104.82	53.47	51.63	54.97
Long-Term Deferred Tax Assets	46.74	20.45	3.97	-	-
Other Long-Term Assets	74.58	0.59	0.33	0.21	0.18
Total Assets	1,516	405.96	255.35	109.81	157.82
Accounts Payable	68.7	32.84	16.81	11.88	5.81
Accrued Expenses	77.39	56.04	37.12	11.67	2.49
Short-Term Debt	-	-	-	0.02	-
Current Portion of Long-Term Debt	18.99	0.96	-	-	0.26
Current Portion of Leases	2.5	0.6	0.64	0.61	0.5
Current Income Taxes Payable	48.58	19.16	7.32	-	-
Current Unearned Revenue	12.18	11.57	5.34	6.2	3.31
Other Current Liabilities	102.59	43.89	18.33	7.6	7.58
Total Current Liabilities	330.91	165.06	85.56	37.98	19.96
Long-Term Debt	551.82	8.21	3.31	-	0.1
Long-Term Leases	8.14	7.68	6.49	1.91	1.35
Long-Term Unearned Revenue	5.36	14.25	24.67	24.54	28.5
Long-Term Deferred Tax Liabilities	9.38	-	-	-	-
Other Long-Term Liabilities	42.11	61.52	55.1	43.09	28.91
Total Liabilities	948.22	257.05	175.35	107.66	78.81
Common Stock	596.78	446.27	370.97	170.84	167.06
Retained Earnings	-212.96	-263.67	-272.82	-173.47	-92.96
Comprehensive Income & Other	184.4	-33.69	-18.15	4.79	4.92
Shareholders' Equity	568.21	148.91	80.01	2.16	79.02
Total Liabilities & Equity	1,516	405.96	255.35	109.81	157.82
Total Debt	581.45	17.45	10.45	2.54	2.21
Net Cash (Debt)	128.9	105.79	105.88	19.5	75.74
Net Cash Growth	21.84%	-0.09%	443.05%	-74.26%	78.35%
Net Cash Per Share	0.37	0.33	0.34	0.07	0.29
Filing Date Shares Outstanding	329.55	323.96	316.71	308.2	280.41
Total Common Shares Outstanding	334.73	323.73	316.34	285.07	280.41
Working Capital	587.65	67.44	87.68	9.56	73.67
Book Value Per Share	1.70	0.46	0.25	0.01	0.28
Tangible Book Value	152.08	39.25	21.02	-53.57	19.83
Tangible Book Value Per Share	0.45	0.12	0.07	-0.19	0.07
Land	26.25	20.75	9.83	2.35	2.46
Machinery	18.56	2.5	1.7	1.85	0.64
Leasehold Improvements	3.26	1.91	1.54	0.38	0.23

Source: S&P Capital IQ. Standard template. Financial Sources.